Second-generation recombinant factor VIII and inhibitor risk: interpretation of RODIN study findings and implications for patients with haemophilia A
- PMID: 24372628
- DOI: 10.1111/hae.12342
Second-generation recombinant factor VIII and inhibitor risk: interpretation of RODIN study findings and implications for patients with haemophilia A
Comment in
-
Making clinical decisions on the basis of RODIN.Haemophilia. 2014 Mar;20(2):e174-5. doi: 10.1111/hae.12361. Haemophilia. 2014. PMID: 24533956 No abstract available.
-
Statistical modelling issues in the RODIN study.Haemophilia. 2014 Jul;20(4):e351-2. doi: 10.1111/hae.12458. Epub 2014 May 14. Haemophilia. 2014. PMID: 24827780 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
